Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.
BMC Infect Dis
; 16(1): 718, 2016 11 29.
Article
in En
| MEDLINE
| ID: mdl-27894270
Full text:
1
Database:
MEDLINE
Main subject:
HIV Infections
/
Anti-HIV Agents
/
Post-Exposure Prophylaxis
/
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
BMC Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2016
Type:
Article
Affiliation country:
France